Abiopharma

Lotus Resources Limited (ASX: LOT, OTCQX: LTSRF) is a leading Africa-focused advanced uranium player with significant scale and resources. Lotus is focused on creating value for its shareholders, its customers and the communities in which it operates, working with local communities to provide meaningful, lasting impact. Lotus is focused on our future. Lotus owns an 85% interest in the Kayelekera Uranium Project in Malawi, and 100% of the Letlhakane Uranium Project in Botswana. The Kayelekera Project hosts a current mineral resource of 51.1Mlbs U3O8, and historically produced ~11MIb of uranium between 2009 and 2014. The Company completed a positive Restart Definitive Study which has determined an Ore Reserve of 23Mlbs U3O8 and demonstrated that Kayelekera as one of the lowest capital cost uranium projects globally whilst also having the ability to quickly recommence production. The Company is progressing the accelerated restart of Kayelekera with first production targeted for Q3 2025. The Letlhakane Project is a greenfield project which hosts a current mineral resource of 113.7Mlbs U3O8. It is in early-stage development project with a mining and environmental licence already in place. Lotus is undertaking a series of technical and engineering studies to optimise the mining and processing strategy for the project.

Additional info from OTC:
Lotus Resources Limited (ASX: LOT, OTCQX: LTSRF) is a leading Africa-focused advanced uranium player with significant scale and resources. Lotus is focused on creating value for its shareholders, its customers and the communities in which it operates, working with local communities to provide meaningful, lasting impact. Lotus is focused on our future. Lotus owns an 85% interest in the Kayelekera Uranium Project in Malawi, and 100% of the Letlhakane Uranium Project in Botswana. The Kayelekera Project hosts a current mineral resource of 51.1Mlbs U3O8, and historically produced ~11MIb of uranium between 2009 and 2014. The Company completed a positive Restart Definitive Study which has determined an Ore Reserve of 23Mlbs U3O8 and demonstrated that Kayelekera as one of the lowest capital cost uranium projects globally whilst also having the ability to quickly recommence production. The Company is progressing the accelerated restart of Kayelekera with first production targeted for Q3 2025. The Letlhakane Project is a greenfield project which hosts a current mineral resource of 113.7Mlbs U3O8. It is in early-stage development project with a mining and environmental licence already in place. Lotus is undertaking a series of technical and engineering studies to optimise the mining and processing strategy for the project.